Overview

Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections

Status:
Completed
Trial end date:
2010-03-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of intravenous CXA 101 and comparator in complicated urinary tract infection
Phase:
Phase 2
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Treatments:
Ceftazidime
Ceftolozane
Cephalosporins